UnitedHealth (NYSE: UNH) director adds shares from dividend equivalents

Rhea-AI Filing Summary

UnitedHealth Group director Kristen L. Gil reported a small change in her holdings of UnitedHealth Group common stock. On 12/16/2025, she acquired 7 shares of common stock at a price of $0, recorded as dividend equivalents paid on vested deferred stock units. After this transaction, she beneficially owned 1,907 shares directly and 3,800 shares indirectly through a trust. The dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gil Kristen

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/16/2025		A		7(1)	A	$0	1,907	D
Common Stock								3,800	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Kristen L. Gil	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UnitedHealth Group (UNH) report for Kristen L. Gil?

Kristen L. Gil, a director of UnitedHealth Group, reported acquiring 7 shares of UnitedHealth Group common stock on 12/16/2025 as dividend equivalents on vested deferred stock units.

At what price were the new UnitedHealth Group (UNH) shares acquired by the director?

The 7 shares of UnitedHealth Group common stock were reported as acquired at a price of $0, reflecting dividend equivalents on vested deferred stock units.

How many UnitedHealth Group (UNH) shares does Kristen L. Gil now beneficially own?

Following the reported transaction, Kristen L. Gil beneficially owns 1,907 shares directly and 3,800 shares indirectly in UnitedHealth Group common stock, with the indirect holdings held by a trust.

What is the nature of the indirect ownership reported for UnitedHealth Group (UNH)?

The filing shows 3,800 shares of UnitedHealth Group common stock as indirectly owned by Kristen L. Gil, held by a trust.

What are the dividend equivalents mentioned in the UnitedHealth Group (UNH) insider filing?

The filing explains that the 7 shares represent dividend equivalents paid on vested deferred stock units. These dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

What is Kristen L. Gil’s relationship to UnitedHealth Group (UNH)?

The report identifies Kristen L. Gil as a director of UnitedHealth Group, and the filing is made as a Form filed by one reporting person.